X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11166) 11166
Publication (685) 685
Book / eBook (492) 492
Book Review (239) 239
Magazine Article (177) 177
Book Chapter (114) 114
Conference Proceeding (10) 10
Dissertation (6) 6
Newspaper Article (6) 6
Newsletter (3) 3
Paper (3) 3
Data Set (1) 1
Report (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8817) 8817
index medicus (5764) 5764
female (4648) 4648
male (4276) 4276
administration, oral (3641) 3641
aged (2791) 2791
middle aged (2685) 2685
warfarin (2545) 2545
anticoagulants (2298) 2298
adult (2277) 2277
risk factors (2103) 2103
anticoagulants - adverse effects (2039) 2039
anticoagulants - therapeutic use (1969) 1969
anticoagulants - administration & dosage (1967) 1967
atrial fibrillation (1914) 1914
treatment outcome (1820) 1820
stroke (1677) 1677
dentistry, oral surgery & medicine (1616) 1616
hemorrhage - chemically induced (1608) 1608
prevention (1601) 1601
surgery (1348) 1348
atrial fibrillation - drug therapy (1297) 1297
cardiac & cardiovascular systems (1290) 1290
aged, 80 and over (1260) 1260
dentistry (1253) 1253
dabigatran (1232) 1232
management (1187) 1187
stroke - prevention & control (1179) 1179
hematology (1165) 1165
peripheral vascular disease (1112) 1112
therapy (1101) 1101
risk (1072) 1072
animals (1059) 1059
rivaroxaban (1050) 1050
atrial fibrillation - complications (1006) 1006
oral anticoagulants (1003) 1003
hemorrhage (997) 997
pharmacology & pharmacy (988) 988
thromboembolism (981) 981
care and treatment (976) 976
analysis (915) 915
medicine & public health (908) 908
atrial-fibrillation (888) 888
medicine, general & internal (877) 877
retrospective studies (876) 876
adolescent (860) 860
oral anticoagulation (837) 837
venous thromboembolism (800) 800
time factors (790) 790
bleeding (785) 785
follow-up studies (772) 772
risk assessment (771) 771
stroke prevention (762) 762
warfarin - therapeutic use (761) 761
health aspects (750) 750
warfarin - adverse effects (750) 750
abridged index medicus (744) 744
prospective studies (731) 731
drug therapy (723) 723
mortality (706) 706
anticoagulation (703) 703
international normalized ratio (686) 686
thromboembolism - prevention & control (686) 686
apixaban (676) 676
stroke - etiology (669) 669
aspirin (668) 668
pregnancy (658) 658
safety (656) 656
warfarin - administration & dosage (649) 649
patients (636) 636
oral hemorrhage - prevention & control (623) 623
antithrombotic therapy (613) 613
thrombosis (602) 602
hemorrhage - prevention & control (591) 591
research (572) 572
clinical trials (554) 554
cardiac arrhythmia (552) 552
risk-factors (550) 550
vitamin k - antagonists & inhibitors (542) 542
internal medicine (517) 517
cardiology (512) 512
young adult (512) 512
double-blind (505) 505
efficacy (505) 505
double-blind method (498) 498
child (490) 490
dosage and administration (486) 486
dose-response relationship, drug (484) 484
metaanalysis (483) 483
complications (477) 477
randomized controlled trials as topic (477) 477
incidence (466) 466
oral anticoagulant-therapy (457) 457
medical research (452) 452
drug administration schedule (432) 432
usage (426) 426
disease (421) 421
medicine (411) 411
molecular-weight heparin (409) 409
platelet aggregation inhibitors - therapeutic use (407) 407
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
UTL at Downsview - May be requested (240) 240
Dentistry (Harry R Abbott) - Stacks (111) 111
Gerstein Science - Stacks (108) 108
Dentistry (Harry R Abbott) - Withdrawn (71) 71
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (61) 61
Robarts - Stacks (19) 19
Collection Dvlpm't (Acquisitions) - Closed Orders (14) 14
Collection Dvlpm't (Acquisitions) - Vendor file (10) 10
Online Resources - Online (8) 8
Dentistry (Harry R Abbott) - May be requested (7) 7
OISE - Stacks (7) 7
UofT at Mississauga - Stacks (7) 7
Dentistry (Harry R Abbott) - Circulation Desk (6) 6
New College (Ivey) - Stacks (5) 5
Dentistry (Harry R Abbott) - Searching (3) 3
Scarborough Hospital - Birchmount (3) 3
Lakeridge Health Sciences - Oshawa (2) 2
St. Augustine's Seminary - Stacks (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
UofT at Scarborough - Stacks (2) 2
Chemistry (A D Allen) - Stacks (1) 1
Dentistry (Harry R Abbott) - Course Reserves (1) 1
Dentistry (Harry R Abbott) - Mending (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
New College (Ivey) - Withdrawn (1) 1
OISE - May be requested in 6-10 wks (1) 1
Robarts - Protected Material (1) 1
Scarborough Hospital - General (1) 1
St Josephs Health Centre - Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
Toronto East General Hospital - Stacks (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UTL at Downsview - Withdrawn (1) 1
University College (Laidlaw) - Stacks (1) 1
UofT at Mississauga - Reference (1) 1
UofT at Scarborough - Missing (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11217) 11217
German (199) 199
French (155) 155
Spanish (105) 105
Italian (71) 71
Japanese (63) 63
Russian (38) 38
Hungarian (20) 20
Dutch (19) 19
Portuguese (19) 19
Polish (15) 15
Arabic (10) 10
Chinese (10) 10
Danish (10) 10
Czech (9) 9
Greek (8) 8
Croatian (7) 7
Romanian (7) 7
Swedish (5) 5
Norwegian (4) 4
Turkish (4) 4
Bulgarian (3) 3
Hebrew (2) 2
Korean (2) 2
Serbian (2) 2
Afrikaans (1) 1
Finnish (1) 1
Ndonga (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BMJ clinical evidence, 2011, Volume 2011
Loss of more than 500 mL of blood following childbirth is usually caused by failure of the uterus to contract fully after delivery of the placenta, and occurs... 
Oxytocin - administration & dosage | Carboprost | Administration, Oral | Humans | Misoprostol - administration & dosage | Oxytocics - administration & dosage | Postpartum Hemorrhage - drug therapy | Female | Postpartum Period
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e152S - e184S
Background: High-quality anticoagulation management is required to keep these narrow therapeutic index medications as effective and safe as possible. This... 
COMPUTERIZED DECISION-SUPPORT | INTENSITY WARFARIN THERAPY | DEFINITE ANTIPHOSPHOLIPID SYNDROME | RESPIRATORY SYSTEM | PROTHROMBIN COMPLEX CONCENTRATE | MOLECULAR-WEIGHT HEPARIN | DEEP-VEIN THROMBOSIS | INTERNATIONAL NORMALIZED RATIO | NONVALVULAR ATRIAL-FIBRILLATION | ACUTE VENOUS THROMBOEMBOLISM | ORAL VITAMIN-K | CRITICAL CARE MEDICINE | United States | Humans | Decision Support Systems, Clinical | Heparin - therapeutic use | Hemorrhage - prevention & control | Long-Term Care | Heparin - adverse effects | Heparin - pharmacokinetics | Dose-Response Relationship, Drug | Fibrinolytic Agents - adverse effects | Vitamin K - antagonists & inhibitors | Drug Interactions | Societies, Medical | Fibrinolytic Agents - pharmacokinetics | Drug-Related Side Effects and Adverse Reactions | Fibrinolytic Agents - therapeutic use | Thrombosis - blood | Thrombosis - prevention & control | Patient Education as Topic | Polysaccharides - therapeutic use | Drug Administration Schedule | Administration, Oral | Hemorrhage - therapy | Polysaccharides - adverse effects | Evidence-Based Medicine | Randomized Controlled Trials as Topic | International Normalized Ratio | Thrombosis - drug therapy | Hemorrhage - chemically induced | Infusions, Intravenous | Self Care | Polysaccharides - pharmacokinetics | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e419S - e496S
Background: This article addresses the treatment of VTE disease. Methods: We generated strong (Grade 1) and weak (Grade 2) recommendations based on... 
RIGHT-VENTRICULAR DYSFUNCTION | RECURRENT VENOUS THROMBOEMBOLISM | TISSUE-PLASMINOGEN-ACTIVATOR | RESPIRATORY SYSTEM | ACUTE PULMONARY-EMBOLISM | MOLECULAR-WEIGHT HEPARIN | VENA-CAVA FILTER | ORAL ANTICOAGULANT-THERAPY | INTRAVENOUS UNFRACTIONATED HEPARIN | LONG-TERM TREATMENT | DEEP-VEIN-THROMBOSIS | CRITICAL CARE MEDICINE | Venous Thrombosis - diagnosis | Pulmonary Embolism - prevention & control | United States | Humans | Venous Thrombosis - blood | Heparin, Low-Molecular-Weight - adverse effects | Hemorrhage - prevention & control | Long-Term Care | Heparin, Low-Molecular-Weight - therapeutic use | Fibrinolytic Agents - adverse effects | Vitamin K - antagonists & inhibitors | Societies, Medical | Fibrinolytic Agents - therapeutic use | Venous Thrombosis - prevention & control | Polysaccharides - therapeutic use | Drug Administration Schedule | Venous Thrombosis - drug therapy | Administration, Oral | Risk Factors | Polysaccharides - adverse effects | Anticoagulants - therapeutic use | Hemorrhage - blood | Anticoagulants - adverse effects | Evidence-Based Medicine | Pulmonary Embolism - blood | International Normalized Ratio | Diagnostic Imaging | Pulmonary Embolism - diagnosis | Pulmonary Embolism - drug therapy | Hemorrhage - chemically induced | Infusions, Intravenous | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e531S - e575S
Background: The risk of stroke varies considerably across different groups of patients with atrial fibrillation (AF). Antithrombotic prophylaxis for stroke is... 
DIRECT-CURRENT CARDIOVERSION | STROKE PREVENTION | RESPIRATORY SYSTEM | CLOPIDOGREL PLUS ASPIRIN | ORAL ANTICOAGULANT-THERAPY | RISK STRATIFICATION SCHEMES | MAJOR VASCULAR EVENTS | PULMONARY-VEIN ABLATION | ACUTE CORONARY SYNDROME | ECHOCARDIOGRAPHY-GUIDED CARDIOVERSION | ANTIARRHYTHMIC-DRUG THERAPY | CRITICAL CARE MEDICINE | Ticlopidine - therapeutic use | Humans | Electric Countershock | Hemorrhage - prevention & control | Dabigatran | Dose-Response Relationship, Drug | Fibrinolytic Agents - adverse effects | Vitamin K - antagonists & inhibitors | Societies, Medical | Aspirin - adverse effects | Fibrinolytic Agents - therapeutic use | Ticlopidine - adverse effects | Aspirin - therapeutic use | Benzimidazoles - adverse effects | Drug Therapy, Combination | beta-Alanine - analogs & derivatives | Benzimidazoles - therapeutic use | Stroke - prevention & control | beta-Alanine - adverse effects | Administration, Oral | Atrial Fibrillation - drug therapy | Risk Factors | Atrial Fibrillation - complications | beta-Alanine - therapeutic use | Anticoagulants - therapeutic use | Hemorrhage - blood | Anticoagulants - adverse effects | Evidence-Based Medicine | Ticlopidine - analogs & derivatives | Atrial Fibrillation - blood | International Normalized Ratio | Stroke - blood | Atrial Flutter - complications | Atrial Flutter - drug therapy | Hemorrhage - chemically induced | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
Circulation, ISSN 0009-7322, 09/2013, Volume 128, Issue 11, pp. 1234 - 1243
BACKGROUND—Patients experiencing major bleeding while taking vitamin K antagonists require rapid vitamin K antagonist reversal. We performed a prospective... 
CARDIAC & CARDIOVASCULAR SYSTEMS | ORAL ANTICOAGULANT REVERSAL | CLINICAL-TRIAL | RECOMBINANT FACTOR-VIII | vitamin K antagonist | prothrombin complex concentrates | PREVIOUSLY UNTREATED PATIENTS | INTRACRANIAL HEMORRHAGE | THERAPY | WARFARIN | TRANSFUSION | HEMOPHILIA-A | anticoagulants | PERIPHERAL VASCULAR DISEASE | plasma | FRESH-FROZEN PLASMA | hemorrhage | Single-Blind Method | Plasma | Prospective Studies | Thromboembolism - chemically induced | Factor IX - therapeutic use | Humans | Middle Aged | Male | Factor IX - adverse effects | Hemorrhage - prevention & control | Vitamin K - antagonists & inhibitors | Thromboembolism - prevention & control | Aged, 80 and over | Adult | Factor X - therapeutic use | Female | Factor X - adverse effects | Factor VII - adverse effects | Factor VII - therapeutic use | Emergencies | Anticoagulants - therapeutic use | Treatment Outcome | Prothrombin - therapeutic use | Anticoagulants - adverse effects | Prothrombin - adverse effects | Hemostatics - adverse effects | International Normalized Ratio | Hemorrhage - drug therapy | Blood Coagulation Factors - adverse effects | Anticoagulants - pharmacology | Blood Coagulation Factors - therapeutic use | Aged | Hemorrhage - chemically induced | Hemostatics - therapeutic use | Drug Combinations | Antidotes - therapeutic use | Antagonists (Biochemistry) | Usage | Care and treatment | Blood coagulation factors | Health aspects | Hemorrhage
Journal Article
BMJ clinical evidence, 12/2008, Volume 2008
Loss of more than 500 mL of blood is usually caused by failure of the uterus to contract fully after delivery of the placenta, and occurs in over 10% of... 
Oxytocin - administration & dosage | Acute Disease | Administration, Oral | Humans | Misoprostol - administration & dosage | Oxytocics - administration & dosage | Postpartum Hemorrhage - drug therapy | Female | Postpartum Period | Labor Stage, Third - drug effects
Journal Article
BJOG: An International Journal of Obstetrics & Gynaecology, ISSN 1470-0328, 07/2012, Volume 119, Issue 8, pp. 975 - 986
Journal Article
Journal Article
Journal Article